corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 6815

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: report

Mintzes B
Paper tiger or toothless tabby? Regulation of prescription drug promotion in Canada
Vancouver: Health Policy Research Unit 1998 Jul


Abstract:

The aim of this paper is to assess the adequacy of current policies to regulate prescription drug promotion in Canada, to briefly present a cmparative international overview and to explore the potential impact of alternative policy initiatives, with an emphasis on identification and discussion of gaps in current regulatory policies.

Keywords:
*analysis/Canada/regulation of promotion/Pharmaceutical Advertising Advisory Board (Can)/Pharmaceutical Manufacturers Association of Canada/direct-to-consumer advertising/DTCA/quality of information/quality of prescribing/ Ethical Criteria for Medicinal Drug Promotion/ International Federation of Pharmaceutical Manufacturers Associations/ IFPMA/ World Health Organization/ WHO/ journal advertisements/ sales representatives/ continuing medical education/ corporate funding/ drug company sponsored research/ patient groups/preclearance of advertisements/ATTITUDES REGARDING PROMOTION: INDUSTRY/ATTITUDES REGARDING PROMOTION: REGULATORS AND GOVERNMENT/EVALUATION OF PROMOTION: DETAILING/EVALUATION OF PROMOTION: DIRECT-TO-CONSUMER ADVERTISING/EVALUATION OF PROMOTION: JOURNAL ADVERTISEMENTS/INFLUENCE OF PROMOTION: CONSUMERS AND PATIENTS/INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION DISGUISED: CLINICAL TRIALS/PROMOTION DISGUISED: SUPPORT FOR CME/PROMOTIONAL TECHNIQUES: INTERNET ADVERTISING/REGULATION, CODES, GUIDELINES: AUTONOMOUS BODIES/REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION/REGULATION, CODES, GUIDELINES: INTERNATIONAL CODES/SPONSORSHIP: PATIENT AND CONSUMER ORGANIZATIONS/VOLUME OF AND EXPENDITURE ON PROMOTION

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963